Purchase Order 75N92E20P00019

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $10,517.76 on March 28, 2019, with completion due April 26, 2019. Place of performance is San Diego, California. The order is firm fixed price with no set-aside category. Specific procurement details regarding the items or services ordered are not provided in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $17,675.00 on September 3, 2019, with ultimate completion on September 3, 2020. No set-aside was used. Work is performed in San Diego, California. The order is firm fixed price.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $17,735.76 on December 21, 2018, with completion by December 25, 2019. The order is a firm fixed price acquisition with no set-aside. Work is performed at Bethesda, Maryland. The purchase order procures DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines serving federal health and research agencies.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on May 8, 2019, with a ceiling value of $17,184.96 for laboratory equipment and instruments.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on April 9, 2019, with a ceiling value of $41,948.93 for genetic sequencing equipment and related services.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $13,250.00 on October 29, 2019, with an ultimate completion date of October 28, 2020. Work is performed in San Diego, California. The order is a firm fixed-price purchase for sequencing reagents, consumables, or related instrumentation—Illumina's core product line sold to NIH institutes and other federal research agencies. No set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute (National Institutes of Health) awarded a purchase order to Illumina, Inc. valued at $208,735.16 on June 5, 2026, for firm fixed-price procurement with no set-aside designation. Work is performed in San Diego, California. The order is scheduled for ultimate completion by September 22, 2027.</p>

<p>The National Human Genome Research Institute issued a $24,926.45 delivery order to Illumina, Inc. on September 19, 2019, under a firm fixed-price structure.</p> <p>Place of performance is Bethesda, MD. The order was due for completion on September 2, 2020. No set-aside was applied to this delivery order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $14,425.00 on January 31, 2018, with ultimate completion on February 1, 2019. Work is performed at North Bethesda, Maryland. The order is a firm fixed price commercial acquisition with no set-aside designation. Specific line items and scope details are not provided in the source material.</p>